Stefan Larson

Stefan joined Sectoral in 2018 as Partner - Private Equity, responsible for leading biotechnology private equity investments. He is currently a director on the boards of eFFECTOR Therapeutics, Turnstone Biologics, Pipeline Therapeutics, and Prilenia Therapeutics BV.

Stefan graduated in 1997 from McGill University with a B.Sc. in Biology, and in 1999 from the University of Toronto with an M.Sc. in Molecular and Medical Genetics. He completed his Ph.D. in Biophysics at Stanford University in 2004.

Prior to joining Sectoral, he was an Entrepreneur-in-Residence and later Venture Partner with Versant Ventures, where he led the establishment of their Toronto-based Discovery Engine and was the founding CEO of Northern Biologics. He was also a co-founder of two medical device companies: Perimeter Medical Imaging, and Tornado Spectral Systems. He began his career at McKinsey & Company in San Francisco and Toronto.